Wide-Complex Tachycardia: Why Ventricular Tachycardia Is the Default Assumption
Cardiac monitor showing a wide-complex tachycardia waveform beside a 12-lead ECG strip

Written by Kate Fitzgerald, BSN, RN, Critical Care Nurse
Medically reviewed by Timothy Fitzgerald, MD, Board-Certified Anesthesiologist
Last reviewed: October 13, 2026

A wide-complex tachycardia on the monitor forces a decision before the differential is even finished: this could be ventricular tachycardia, or it could be supraventricular tachycardia with aberrant conduction, and the two are not treated the same way. Reading a rhythm strip in 60 seconds gets a provider to “wide and fast” quickly. Getting from “wide and fast” to the right treatment is a different problem, and it’s the one this post is built around.

The honest starting point is that even experienced clinicians misclassify wide-complex tachycardia under pressure, and the literature on this is blunt: when a wide-complex tachycardia turns out to be something other than VT, it’s far more often VT misread as SVT than the reverse. That asymmetry is exactly why the default assumption has to run in one direction.

The Default Rule: Wide and Fast Is VT Until Proven Otherwise

Roughly 80% of wide-complex tachycardias are ventricular in origin. Most of the rest are supraventricular tachycardia conducting through a bundle branch block, an accessory pathway, or a rate-related aberrancy — not a separate category of arrhythmia, but a narrow-complex rhythm wearing a wide QRS. The base rate alone should set the default: treat a wide-complex tachycardia as VT until something specific proves otherwise, not the other way around.

This matters because the two treatment paths diverge in exactly the place where a wrong guess does the most damage — the drugs used to slow a supraventricular rhythm can accelerate or destabilize a ventricular one.

What Points Toward VT

AV dissociation. P waves marching through the QRS complexes at their own independent rate, unrelated to ventricular activity, is one of the most specific findings for VT. It’s also one of the hardest to spot at a fast rate, which is part of why VT gets missed.

Capture and fusion beats. An occasional narrow QRS breaking up the wide-complex pattern (a capture beat) or a QRS that looks like a blend of the native and ventricular morphology (a fusion beat) both indicate two independent pacemakers competing for the ventricles — a VT signature.

Extreme axis deviation. A QRS axis in the “northwest” quadrant (negative in both lead I and lead aVF) is unusual for any supraventricular rhythm and strongly favors a ventricular origin.

Precordial concordance. If every QRS complex from V1 through V6 points the same direction — all positive or all negative — that’s concordance, and it’s a strong VT indicator. SVT with aberrancy almost never produces it.

QRS duration and morphology. A QRS wider than 0.14 seconds with a right-bundle-branch-block-like shape, or wider than 0.16 seconds with a left-bundle-branch-block-like shape, favors VT. Validated algorithms (Brugada’s criteria, the Vereckei criteria) formalize this into a stepwise read, but the underlying logic is simple: the wider and stranger the QRS, the less likely it’s a rhythm using the heart’s normal conduction pathway.

History of structural heart disease. A patient with a prior MI, cardiomyopathy, or known scar tissue is a patient whose wide-complex tachycardia is VT until proven otherwise with even more certainty than the base rate alone suggests — scar tissue is what ventricular tachycardia circuits are built on.

What Points Toward SVT with Aberrancy

A QRS morphology that matches a known baseline. If a prior ECG on file shows the same bundle branch block pattern at a normal rate, that’s meaningful evidence the wide complex now is the same aberrancy, just faster — not a new ventricular rhythm.

A structurally normal heart and a younger patient. SVT with aberrancy is far more common in patients without underlying heart disease. It doesn’t rule out VT on its own, but it shifts the odds.

Abrupt onset and offset. Classic paroxysmal SVT starts and stops suddenly, which is a pattern consistent with a reentrant supraventricular circuit rather than a ventricular focus.

None of these findings is definitive on its own, and that’s the point: SVT with aberrancy is a diagnosis that gets stronger with supporting evidence, while VT is the diagnosis that only needs the absence of that evidence to stay the default.

Why Guessing Wrong Is Costly

The reason this differential gets its own post instead of a footnote is that the wrong call isn’t neutral — some of the drugs used to manage SVT are actively dangerous if the rhythm is actually VT.

Calcium channel blockers (verapamil, diltiazem) given to a wide-complex tachycardia that turns out to be VT can cause rapid hemodynamic collapse by blocking calcium influx the ventricle needs to maintain contractility against an already-compromised rhythm. They are not given empirically for an undifferentiated wide-complex tachycardia, full stop.

Adenosine is safer but not a substitute for the differential above. It’s sometimes used as a diagnostic-and-therapeutic trial in a stable, regular, monomorphic wide-complex tachycardia — if it’s SVT with aberrancy, adenosine will typically terminate or at least transiently slow it. But adenosine is avoided in irregular or polymorphic wide-complex tachycardia, because an irregular wide-complex rhythm raises the possibility of atrial fibrillation conducting down an accessory pathway (pre-excited AF), and adenosine in that setting can accelerate conduction through the accessory pathway and precipitate ventricular fibrillation.

What to Do When It’s Genuinely Unclear

An unstable patient doesn’t wait for the differential to resolve. Unstable wide-complex tachycardia — VT or SVT with aberrancy — gets synchronized cardioversion, the same pathway ventricular tachycardia with a pulse already follows when the patient is unstable.

A stable patient with a regular, monomorphic wide-complex tachycardia and an unclear differential is managed as presumed VT: amiodarone, procainamide, or sotalol, per the ACLS tachycardia algorithm. Calcium channel blockers and, in the irregular or pre-excited case, adenosine stay off the table. If the rhythm is irregular and wide, torsades de pointes and pre-excited AF both belong in the differential alongside monomorphic VT, and they change the management further — which is exactly why “wide and fast” is a starting point for the five-step read, not an endpoint.

Where This Fits in the Algorithm

The ACLS Tachycardia Algorithm branches on stability first and QRS width second — stable or unstable, then narrow or wide. Narrow-complex tachycardia resolves largely through vagal maneuvers and adenosine because the rhythm is, almost by definition, supraventricular. Wide-complex tachycardia doesn’t get that shortcut, because the whole problem is that the strip alone can’t always confirm where the rhythm is coming from. The algorithm compensates by defaulting to the more dangerous diagnosis rather than the more common drug.

Bottom Line

Most wide-complex tachycardia is ventricular tachycardia, and the ECG findings that argue for SVT with aberrancy — a matching baseline morphology, a structurally normal heart, abrupt onset — have to outweigh that base rate, not just exist alongside it. The cost of treating VT as if it were SVT is a patient given a calcium channel blocker that drops their pressure further; the cost of treating SVT as if it were VT is, at worst, an antiarrhythmic a stable patient didn’t strictly need. That asymmetry is the whole argument for the default rule.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn